Novel peptides represent an emerging landscape in therapeutic research. Such brief chains of building acids present significant promise for interacting with intractable pathways involved in multiple diseases. Early research demonstrate that can achieve specific interaction and demonstrate desirable bioavailability characteristics, opening paths to